Relax and scientifically deal with the prevention and treatment of COVID-19
2022-12-13
Winter is a period of high incidence of respiratory diseases, and the COVID-19 also has spread risks. As China's epidemic prevention and control measures continue to optimize, restrictive measures continue to reduce, the number of infected people will certainly increase in the short term. For this reason, the joint prevention and control mechanism of the State Council issued the Guidelines for Home Treatment of COVID-19 Infected Persons, and attached the Reference Table of Common Drugs for Home Treatment of COVID-19 Infected Persons. Common drugs were listed according to seven symptoms, such as fever, dry throat and sore throat, and acetaminophen, ibuprofen, aspirin, Lianhua Qingwen Granules/capsules and other drugs were included in the reference table. Recently, one of the most concerned things of the national people is how to recover from COVID-19 infection as soon as possible. The contradiction of relevant information on the Internet makes people more confused. Due to the lack of sufficient pharmaceutical knowledge among many people, various folk prescriptions once circulated on the Internet; In addition, some people do not have enough knowledge of the Omicron mutant, which makes them prone to sudden treatment when they are infected at home. In the face of these conditions, it is timely to release the Reference Table of Common Drugs for Home Treatment of COVID-19 Infected Persons. With the support of scientific research conclusions, the general public should maintain peace of mind after being infected with COVID-19. Based on the guidelines for home treatment and the reference table for commonly used drugs issued by the joint prevention and control mechanism of the State Council, it is imperative to further publicize the drug use norms to the public. At present, many medical experts all over the country are calling for that, in case of an emergency, one should not use western medicine for fever and traditional Chinese medicine for cold, while ibuprofen and acetaminophen should not be used together, and only one symptomatic drug should be selected. Such an appeal is necessary to avoid the occurrence of drug poisoning and other problems caused by overuse of drugs during home treatment. The COVID-19 Omikron mutant is not terrible, which is the result of scientific and practical proof. For this, the general public need not be too nervous, and should correctly and scientifically deal with various problems that may arise. The variant strain of Omikjon BF. 7 is the main strain of this round of epidemic in Beijing. According to experts, BF The mutant strain is the most powerful sub branch of the Omicron family in China, with stronger infectivity and concealment, but its virulence is also very low. Zhong Nanshan, an academician of the CAE Member, also said recently that at present, in Guangzhou, Omicron is mainly BA. 4 and BA. 5, and there is a small amount of BA in China 7. The morbidity is low. Most people can get better in 5 to 7 days without treatment as long as they have a good rest. The current adjustment of the epidemic prevention and control policy is based on the correct situation analysis, and the view that some people put forward that "it is not better to get infected earlier" is not correct. A single infection of COVID-19 does not provide lifelong immunity, and there is also a certain probability of a second infection. At this stage, the general public should still insist on not gathering unnecessarily, wear masks when traveling, and do a good job of self-protection. At the same time, protecting yourself at this stage can delay the arrival of the peak of COVID-19 infection to a certain extent, help the medical system gain time to adjust the response plan of medical institutions as soon as possible, and mobilize medical resources. This is not only a help for patients with possible critical illness, but also conducive to social forces to seize the supply and reserve of common cold medicines, so that every citizen
Edit:qihang Responsible editor:xinglan
Source:https://epaper.gmw.cn/gmrb/html/2022-12/13/nw.D110000gmrb_20221213_5-07.htm
Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email:lwxsd@liaowanghn.com